首页> 外文期刊>Lancet Neurology >Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial
【24h】

Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial

机译:在第三次国际卒中试验(IST-3)中,脑影像体征,早期和晚期结局与急性缺血性卒中后对静脉阿替普酶的反应之间的关联:一项随机对照试验的二次分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background Brain scans are essential to exclude haemorrhage in patients with suspected acute ischaemic stroke before treatment with alteplase. However, patients with early ischaemic signs could be at increased risk of haemorrhage after alteplase treatment, and little information is available about whether pre-existing structural signs, which are common in older patients, affect response to alteplase. We aimed to investigate the association between imaging signs on brain CT and outcomes after alteplase.
机译:背景技术在使用阿替普酶治疗之前,脑部扫描对于排除疑似急性缺血性中风患者的出血至关重要。但是,具有早期缺血性体征的患者在接受阿替普酶治疗后出血的风险可能会增加,并且关于老年患者常见的既有结构性体征是否会影响对阿替普酶的反应的信息很少。我们旨在研究阿替普酶治疗后脑部CT影像表现与预后之间的关系。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号